Pediatric Studies for PPIs: Are Placebo-Controlled Trials In Infants Unethical?
Executive Summary
FDA is asking its pediatric advisory subcommittee to consider whether the agency's requirements for pediatric studies of proton pump inhibitors in infants under one year of age raise ethical concerns